Sterile Fecal Microbiota Transplantation Boosts Anti-Inflammatory T-Cell Response in Ulcerative Colitis Patients

Int J Mol Sci. 2024 Feb 4;25(3):1886. doi: 10.3390/ijms25031886.

Abstract

Ulcerative colitis is a chronic immune-mediated disease of unclear etiology, affecting people of different ages and significantly reducing the quality of life. Modern methods of therapy are mainly represented by anti-inflammatory drugs and are not aimed at a specific pathogenetic factor. In this study, we investigated the effect of transplantation of sterile stool filtrate from healthy donors on the induction of anti-inflammatory immune mechanisms. It was shown that performing such a procedure in patients with ulcerative colitis caused the appearance of T helper cells in the blood, which reacted to the content of sterile stool filtrates in an antigen-specific manner and produced IL-10. At the same time, cells of the same patients before therapy in response to the addition of sterile stool filtrates were less reactive and predominantly produced IL-4, indicating its pro-inflammatory skewing. The obtained data demonstrated the effect of an anti-inflammatory shift in the T-helper response after transplantation of sterile stool filtrate, which increased and persisted for at least three months after the procedure.

Keywords: immune response; regulatory T cells; sterile fecal microbiota transplantation; ulcerative colitis.

MeSH terms

  • Anti-Inflammatory Agents
  • Colitis, Ulcerative* / etiology
  • Colitis, Ulcerative* / therapy
  • Fecal Microbiota Transplantation / methods
  • Feces
  • Gastrointestinal Microbiome*
  • Humans
  • Quality of Life
  • T-Lymphocytes, Helper-Inducer

Substances

  • Anti-Inflammatory Agents